News

An IMB researcher has received funding to create a simple, affordable biosensor for monitoring biological information in real time.

An international team of researchers has found a drug previously approved to treat breast cancer could also be used to shrink medulloblastoma, a common form of childhood brain tumour.

A research paper published in Nature journal overnight revealed that scientists had successfully edited the genomes of human embryos to prevent a mutation that causes hypertrophic cardiomyopathy, an inherited condition that causes sudden heart failure in young people.

IMB scientists have discovered a promising new approach to treat pain from tarantula venom.

IMB researchers are identifying pathways that contribute to pain, to help the one in five Australians who live with chronic pain.

Across Australia’s vast outback, parasitic worms are crippling sheep production. The little-known, blood-sucking Barber's Pole worm is one of the most dangerous, commonly killing infected sheep.

IMB's Dr Larisa Labzin has won the NHMRC Frank Fenner Award for having the top-ranked early career research fellowship in 2016.

Professor Peter Koopman speaks about his research into CRISPR and the possibilities it could offer to future generations, as well as those suffering from genetic conditions right now.

A discovery by University of Queensland researchers about the evolution of a tiny fish could have implications for sufferers of muscle diseases such as muscular dystrophy.

IMB PhD student Andrew White will network with Nobel Prize winners at the 67th Lindau Nobel Laureate Meeting later this month.

Professor Yang, a statistical genomics researcher, received the Senior Researcher Award at the Queensland ASMR Gala Dinner in Brisbane on 2 June during ASMR Medical Research Week.

UQ IMB spinout company, Protagonist Therapeutics Inc., recently announced that it has initiated a Phase 1 clinical study and entered into a $1 billion worldwide agreement with a global pharmaceutical company.

In the world’s largest study into the genetic causes of endometriosis, Institute for Molecular Bioscience researchers have helped identify five new gene regions linked to the disease.

A new gene behind a rare form of inherited childhood kidney disease has been identified by a global research team. UQ IMB researchers were part of the team that made the discovery that will improve genetic testing and could provide clues for future treatments for autosomal recessive polycystic kidney disease (ARPKD).

Advances in life science research provide critical knowledge across a wide range of biological fields, informing everything from our fundamental understanding of evolutionary biology to remarkable progress in personalised medicine. In order to ensure the security and global accessibility of molecular data, a concerted effort must be toward shared responsibility for the support and maintenance of core data resources.

Learn how the IMB Centre for Solar Biotechnology is using algae to power a more sustainable future.

Learn how the Butterfly Pea gave rise to a world first for natural insecticide.

Researchers from The University of Queensland are seeking the help of Australian mothers to identify the genetic factors involved in postpartum depression, which will help us understand and develop better ways to prevent, diagnose and treat the condition.

The brain has its own inbuilt processes for mopping up damaging cellular waste – and these processes may provide protection from stroke and dementia. UQ scientists discovered a new type of lymphatic brain “scavenger” cell by studying tropical freshwater zebrafish – which share many of the same cell types and organs as humans.

Repairing damaged heart and vascular tissues will be the unique focus of a new University of Queensland research centre, established to combat cardiovascular disease. The UQ Centre for Cardiac and Vascular Biology (CCVB) brings together eight laboratories researching cardiovascular development, regeneration and disease.